Because lung cancer has a high mutational burden (34) and certain TKIs have been applied in patients with somatic mutations in EGFR or translocations involving ALK or ROS1 (35), genetic instability should be a sensitive risk predictor. This evidence concerns the gene EGFR and lung cancer.